Victory Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,200
| Closed | -$490K | – | 2781 |
|
|
2022
Q3 | $490K | Buy |
7,200
+66
| +0.9% | +$4.49K | ﹤0.01% | 2065 |
|
|
2022
Q2 | $228K | Sell |
7,134
-18
| -0.3% | -$575 | ﹤0.01% | 2313 |
|
|
2022
Q1 | $220K | Sell |
7,152
-536
| -7% | -$16.5K | ﹤0.01% | 2390 |
|
|
2021
Q4 | $225K | Buy |
+7,688
| New | +$225K | ﹤0.01% | 2457 |
|
|
2021
Q3 | – | Sell |
-7,457
| Closed | -$261K | – | 2877 |
|
|
2021
Q2 | $261K | Buy |
7,457
+490
| +7% | +$17.2K | ﹤0.01% | 2463 |
|
|
2021
Q1 | $284K | Buy |
6,967
+31
| +0.4% | +$1.26K | ﹤0.01% | 2417 |
|
|
2020
Q4 | $300K | Buy |
6,936
+1,375
| +25% | +$59.5K | ﹤0.01% | 2285 |
|
|
2020
Q3 | $307K | Sell |
5,561
-178
| -3% | -$9.83K | ﹤0.01% | 2153 |
|
|
2020
Q2 | $362K | Sell |
5,739
-6,905
| -55% | -$436K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $646K | Buy |
12,644
+3,741
| +42% | +$191K | ﹤0.01% | 2005 |
|
|
2019
Q4 | $708K | Buy |
8,903
+1,895
| +27% | +$151K | ﹤0.01% | 1858 |
|
|
2019
Q3 | $340K | Buy |
+7,008
| New | +$340K | ﹤0.01% | 2029 |
|